ID

38216

Description

Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02472353

Lien

https://clinicaltrials.gov/show/NCT02472353

Mots-clés

Versions (1)
  1. 28/09/2019 28/09/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

28 septembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT02472353

Anglais

Eligibility Breast Cancer NCT02472353

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
breast cancer requiring neoadjuvant or adjuvant therapy with doxorubicin
Description

Breast Carcinoma | Requirement Doxorubicin Neoadjuvant Therapy | Requirement Doxorubicin Adjuvant therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C0013089
UMLS CUI [2,3]
C0600558
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0013089
UMLS CUI [3,3]
C0677850
complete metabolic panel demonstrating adequate organ functions as defined by the following: ast less than 2.5 times uln; alt less than 2.5 times uln; alkaline phosphatase less than 2.5 times uln; serum creatinine less than 1.5 mg/dl; serum bilirubin less than uln
Description

Metabolic Panel Complete | Organ function | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement | Creatinine measurement, serum | Serum total bilirubin measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C4281808
UMLS CUI [1,2]
C0205197
UMLS CUI [2]
C0678852
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201836
UMLS CUI [5]
C0201850
UMLS CUI [6]
C0201976
UMLS CUI [7]
C1278039
ecog performance status of 0 or 1
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
age greater than or equal to 21 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known diabetes
Description

Diabetes Mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0011849
history of cardiac arrhythmias or symptomatic cardiac disease
Description

Cardiac Arrhythmia | Heart Disease Symptomatic

Type de données

boolean

Alias
UMLS CUI [1]
C0003811
UMLS CUI [2,1]
C0018799
UMLS CUI [2,2]
C0231220
currently taking antiarrhythmic medications, beta-blockers, or other rate controlling cardiac medications
Description

Anti-Arrhythmia Agents | Adrenergic beta-1 Receptor Antagonists | Pharmaceutical Preparations Heart rate Control

Type de données

boolean

Alias
UMLS CUI [1]
C0003195
UMLS CUI [2]
C0304516
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0018810
UMLS CUI [3,3]
C2587213
currently taking metformin and/or sulfonylureas
Description

Metformin | Sulfonylureas

Type de données

boolean

Alias
UMLS CUI [1]
C0025598
UMLS CUI [2]
C0038766
known hypersensitivity or intolerance to metformin
Description

Metformin allergy | intolerance to Metformin

Type de données

boolean

Alias
UMLS CUI [1]
C0571648
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0025598
baseline ejection fraction of less than 50% measured by echocardiogram
Description

Cardiac ejection fraction Echocardiography

Type de données

boolean

Alias
UMLS CUI [1,1]
C0232174
UMLS CUI [1,2]
C0013516
known hypersensitivity to contrast used during echocardiogram
Description

Contrast media allergy | Contrast echocardiography Related

Type de données

boolean

Alias
UMLS CUI [1]
C0570562
UMLS CUI [2,1]
C0013518
UMLS CUI [2,2]
C0439849
risk factors associated with increased risk of metformin-associated lactic acidosis (e.g. congestive heard failure, history of acidosis, habitual intake of 3 or more alcoholic beverages per day)
Description

Risk factors | Risk Lactic Acidosis Metformin Induced | Congestive heart failure | Acidosis | Alcoholic Beverages U/day

Type de données

boolean

Alias
UMLS CUI [1]
C0035648
UMLS CUI [2,1]
C0035647
UMLS CUI [2,2]
C0001125
UMLS CUI [2,3]
C0025598
UMLS CUI [2,4]
C0205263
UMLS CUI [3]
C0018802
UMLS CUI [4]
C0001122
UMLS CUI [5,1]
C0001967
UMLS CUI [5,2]
C0456683
pregnant or breast feeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT02472353

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma | Requirement Doxorubicin Neoadjuvant Therapy | Requirement Doxorubicin Adjuvant therapy
Item
breast cancer requiring neoadjuvant or adjuvant therapy with doxorubicin
boolean
C0678222 (UMLS CUI [1])
C1514873 (UMLS CUI [2,1])
C0013089 (UMLS CUI [2,2])
C0600558 (UMLS CUI [2,3])
C1514873 (UMLS CUI [3,1])
C0013089 (UMLS CUI [3,2])
C0677850 (UMLS CUI [3,3])
Metabolic Panel Complete | Organ function | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement | Creatinine measurement, serum | Serum total bilirubin measurement
Item
complete metabolic panel demonstrating adequate organ functions as defined by the following: ast less than 2.5 times uln; alt less than 2.5 times uln; alkaline phosphatase less than 2.5 times uln; serum creatinine less than 1.5 mg/dl; serum bilirubin less than uln
boolean
C4281808 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0678852 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0201850 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
C1278039 (UMLS CUI [7])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Age
Item
age greater than or equal to 21 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus
Item
known diabetes
boolean
C0011849 (UMLS CUI [1])
Cardiac Arrhythmia | Heart Disease Symptomatic
Item
history of cardiac arrhythmias or symptomatic cardiac disease
boolean
C0003811 (UMLS CUI [1])
C0018799 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
Anti-Arrhythmia Agents | Adrenergic beta-1 Receptor Antagonists | Pharmaceutical Preparations Heart rate Control
Item
currently taking antiarrhythmic medications, beta-blockers, or other rate controlling cardiac medications
boolean
C0003195 (UMLS CUI [1])
C0304516 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C0018810 (UMLS CUI [3,2])
C2587213 (UMLS CUI [3,3])
Metformin | Sulfonylureas
Item
currently taking metformin and/or sulfonylureas
boolean
C0025598 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
Metformin allergy | intolerance to Metformin
Item
known hypersensitivity or intolerance to metformin
boolean
C0571648 (UMLS CUI [1])
C1744706 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Cardiac ejection fraction Echocardiography
Item
baseline ejection fraction of less than 50% measured by echocardiogram
boolean
C0232174 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
Contrast media allergy | Contrast echocardiography Related
Item
known hypersensitivity to contrast used during echocardiogram
boolean
C0570562 (UMLS CUI [1])
C0013518 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
Risk factors | Risk Lactic Acidosis Metformin Induced | Congestive heart failure | Acidosis | Alcoholic Beverages U/day
Item
risk factors associated with increased risk of metformin-associated lactic acidosis (e.g. congestive heard failure, history of acidosis, habitual intake of 3 or more alcoholic beverages per day)
boolean
C0035648 (UMLS CUI [1])
C0035647 (UMLS CUI [2,1])
C0001125 (UMLS CUI [2,2])
C0025598 (UMLS CUI [2,3])
C0205263 (UMLS CUI [2,4])
C0018802 (UMLS CUI [3])
C0001122 (UMLS CUI [4])
C0001967 (UMLS CUI [5,1])
C0456683 (UMLS CUI [5,2])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial